CervoMed Inc. Diluted Shares Outstanding (Weighted Average)
CervoMed Inc. (CRVO) reported Diluted Shares Outstanding (Weighted Average) of 8.70 million shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2024-11-12
- CervoMed Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 8.70M shares, a 131.04% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-09-30 was 3.77M shares, a 626.97% increase year-over-year.
- CervoMed Inc. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 518.14K shares.
- CervoMed Inc. weighted average number of shares outstanding, diluted for the quarter ending 2018-12-31 was -130.36M shares.
- CervoMed Inc. weighted average number of shares outstanding, diluted for fiscal 2018 was 3.24M shares, a 282.31% increase from fiscal 2017.
- CervoMed Inc. weighted average number of shares outstanding, diluted for fiscal 2017 was 848.09K shares, a 91.71% decline from fiscal 2016.
- CervoMed Inc. weighted average number of shares outstanding, diluted for fiscal 2016 was 10.23M shares, a 45.03% decline from fiscal 2015.
- CervoMed Inc. weighted average number of shares outstanding, diluted for fiscal 2015 was 18.61M shares, a 30.18% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 8.70M shares 10-Q · filed 2024-11-12 | 7.86M shares 10-Q · filed 2024-11-12 | ||||||
| 2023-09-30 | 3.77M shares 10-Q · filed 2024-11-12 | 2.21M shares 10-Q · filed 2024-11-12 | ||||||
| 2022-09-30 | 518.14K shares 10-Q · filed 2023-11-13 | 518.14K shares 10-Q · filed 2023-11-13 | ||||||
| 2018-12-31 | -130.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -39.90M shares derived: average of 2 quarters · filed 2019-03-19 | -9.75M shares derived: average of 3 quarters · filed 2019-03-19 | 3.24M shares 10-K · filed 2019-03-19 | ||||
| 2018-09-30 | 50.57M shares 10-Q · filed 2018-11-13 | 50.56M shares derived: average of 2 quarters · filed 2018-11-13 | 47.78M shares 10-Q · filed 2018-11-13 | |||||
| 2018-06-30 | 50.55M shares 10-Q · filed 2018-08-10 | 46.36M shares 10-Q · filed 2018-08-10 | ||||||
| 2017-12-31 | -34.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -9.73M shares derived: average of 2 quarters · filed 2019-03-19 | -1.87M shares derived: average of 3 quarters · filed 2019-03-19 | 848.09K shares 10-K · filed 2019-03-19 | 12.76M shares 10-K · filed 2018-04-02 | |||
| 2017-09-30 | 14.71M shares 10-Q · filed 2018-11-13 | 14.29M shares derived: average of 2 quarters · filed 2018-11-13 | 12.53M shares 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | 13.87M shares 10-Q · filed 2018-08-10 | 12.34M shares 10-Q · filed 2018-08-10 | ||||||
| 2016-12-31 | 10.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 10.33M shares derived: average of 2 quarters · filed 2018-04-02 | 10.31M shares derived: average of 3 quarters · filed 2018-04-02 | 10.23M shares 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | 10.33M shares 10-Q · filed 2017-11-13 | 10.30M shares derived: average of 2 quarters · filed 2017-11-13 | 10.20M shares 10-Q · filed 2017-11-13 | |||||
| 2016-06-30 | 10.26M shares 10-Q · filed 2017-08-14 | 10.13M shares 10-Q · filed 2017-08-14 | ||||||
| 2015-12-31 | 18.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 18.61M shares derived: average of 2 quarters · filed 2016-03-25 | 18.61M shares derived: average of 3 quarters · filed 2016-03-25 | 18.61M shares 10-K · filed 2016-03-25 | ||||
| 2015-09-30 | 18.61M shares 10-Q · filed 2015-11-12 | 18.61M shares derived: average of 2 quarters · filed 2015-11-12 | 18.61M shares 10-Q · filed 2015-11-12 | 19.14M shares derived: average of 4 quarters · filed 2016-03-25 | ||||
| 2015-06-30 | 18.61M shares 10-Q · filed 2015-08-12 | 18.61M shares 10-Q · filed 2015-08-12 | 19.32M shares derived: average of 3 quarters · filed 2016-03-25 | 19.16M shares derived: average of 4 quarters · filed 2016-03-25 | ||||
| 2015-03-31 | 18.61M shares 10-Q · filed 2015-05-11 | 19.67M shares derived: average of 2 quarters · filed 2016-03-25 | 19.34M shares derived: average of 3 quarters · filed 2016-03-25 | 17.72M shares derived: average of 4 quarters · filed 2016-03-25 | ||||
| 2014-12-31 | 20.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 19.70M shares derived: average of 2 quarters · filed 2016-03-25 | 17.42M shares derived: average of 3 quarters · filed 2016-03-25 | 14.30M shares 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | 18.67M shares 10-Q · filed 2015-11-12 | 15.77M shares derived: average of 2 quarters · filed 2015-11-12 | 12.16M shares 10-Q · filed 2015-11-12 | 10.03M shares derived: average of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | 12.87M shares 10-Q · filed 2015-08-12 | 9.48M shares 10-Q · filed 2015-08-12 | 7.15M shares derived: average of 3 quarters · filed 2015-08-12 | 6.40M shares derived: average of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | 5.93M shares 10-Q · filed 2015-05-11 | 4.29M shares derived: average of 2 quarters · filed 2015-05-11 | 4.24M shares derived: average of 3 quarters · filed 2015-05-11 | 3.90M shares derived: average of 4 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | 2.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | 3.40M shares derived: average of 2 quarters · filed 2015-04-03 | 3.22M shares derived: average of 3 quarters · filed 2015-04-03 | 2.65M shares 10-K · filed 2015-04-03 | ||||
| 2013-09-30 | 4.14M shares 10-Q · filed 2014-11-12 | 414.40M shares 10-Q · filed 2013-11-19 | 3.50M shares derived: average of 2 quarters · filed 2014-11-12 | 2.65M shares 10-Q · filed 2014-11-12 | 264.66M shares 10-Q · filed 2013-11-19 | -84.86M shares derived: average of 4 quarters · filed 2014-11-12 | ||
| 2013-06-30 | 2.86M shares 10-Q · filed 2014-08-14 | 286.23M shares 10-Q · filed 2013-08-14 | 1.89M shares 10-Q · filed 2014-08-14 | 188.55M shares 10-Q · filed 2013-08-14 | -114.53M shares derived: average of 3 quarters · filed 2014-08-14 | -56.42M shares derived: average of 4 quarters · filed 2014-08-14 | ||
| 2013-03-31 | 1.21M shares 10-Q · filed 2014-05-20 | 120.75M shares 10-Q/A · filed 2013-05-20 | -173.23M shares derived: average of 2 quarters · filed 2014-05-20 | -76.18M shares derived: average of 3 quarters · filed 2014-05-20 | -27.66M shares derived: average of 4 quarters · filed 2014-05-20 | |||
| 2012-12-31 | -347.67M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | -114.88M shares derived: average of 2 quarters · filed 2014-04-23 | -37.28M shares derived: average of 3 quarters · filed 2014-04-23 | 1.12M shares 10-K/A · filed 2014-04-23 | 112.20M shares 10-K/A · filed 2013-04-24 | |||
| 2012-09-30 | 117.92M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | 117.92M shares derived: average of 2 quarters · filed 2013-11-19 | 117.39M shares 10-Q · filed 2013-11-19 | |||||
| 2012-06-30 | 117.92M shares 10-Q · filed 2013-11-19 | 116.35M shares 10-Q · filed 2013-08-14 | 117.12M shares 10-Q · filed 2013-08-14 | |||||
| 2012-03-31 | 109.41M shares 10-Q/A · filed 2013-05-20 | |||||||
| 2011-12-31 | 101.02M shares 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |